{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:25:49Z","timestamp":1782325549585,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>In this single-center retrospective study, we intended to evaluate the frequencies and characteristics of computed tomography findings of pancreatobiliary inflammation (PBI) in patients treated with lenvatinib and the relationship of these findings with treatment-planning changes.<\/jats:p>\n            <jats:p>We included 78 patients (mean\u200a\u00b1\u200astandard deviation, 69.8\u200a\u00b1\u200a9.4\u200ayears, range: 39\u201384\u200ayears, 62 men) with hepatocellular carcinoma (n\u200a=\u200a62) or thyroid carcinoma (n\u200a=\u200a16) who received lenvatinib (June 2016\u2013September 2020). Two radiologists interpreted the posttreatment computed tomography images and assessed the radiological findings of PBI (symptomatic pancreatitis, cholecystitis, or cholangitis). The PBI effect on treatment was statistically evaluated.<\/jats:p>\n            <jats:p>PBI (pancreatitis, n\u200a=\u200a1; cholecystitis, n\u200a=\u200a7; and cholangitis, n\u200a=\u200a2) was diagnosed in 11.5% (9\/78) of the patients at a median of 35\u200adays after treatment initiation; 6 of 9 patients discontinued treatment because of PBI. Three cases of cholecystitis and 1 of cholangitis were accompanied by gallstones, while the other 5 were acalculous. The treatment duration was significantly shorter in patients with PBI than in those without (median: 44\u200adays vs. 201\u200adays, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02). Overall, 9 of 69 patients without PBI showed asymptomatic gallbladder subserosal edema.<\/jats:p>\n            <jats:p>Lenvatinib-induced PBI developed in 11.5% of patients, leading to a significantly shorter treatment duration. Approximately 55.6% of the PBI cases were acalculous. The recognition of this phenomenon would aid physicians during treatment planning in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027182","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T17:35:00Z","timestamp":1630949700000},"page":"e27182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Incidence and computed tomography findings of lenvatinib-induced pancreatobiliary inflammation"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1186-8900","authenticated-orcid":false,"given":"Ryo","family":"Kurokawa","sequence":"first","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Tanishima","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moto","family":"Nakaya","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Gonoi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunaga","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.22263","article-title":"Sorafenib, a multikinase inhibitor, is effective in vitro against non-Hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin","volume":"87","author":"Ramakrishnan","year":"2012","journal-title":"Am J Hematol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1186\/s12885-019-6369-7","article-title":"A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine","volume":"19","author":"Fleeman","year":"2019","journal-title":"BMC Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.seminoncol.2018.11.004","article-title":"Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer","volume":"46","author":"Cabanillas","year":"2019","journal-title":"Semin Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/MPA.0000000000001061","article-title":"Lenvatinib-induced acute pancreatitis associated with a pancreatic pseudocyst and splenic pseudoaneurysms","volume":"47","author":"Kawakami","year":"2018","journal-title":"Pancreas"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2169\/internalmedicine.3806-19","article-title":"Repeated perforation of the gallbladder in a patient with hepatocellular carcinoma receiving lenvatinib","volume":"59","author":"Honda","year":"2020","journal-title":"Intern Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jhbp.515","article-title":"Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)","volume":"25","author":"Yokoe","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"W221","DOI":"10.2214\/AJR.10.4338","article-title":"Imaging of acute pancreatitis","volume":"197","author":"O\u2019Connor","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13017-019-0247-0","article-title":"2019 WSES guidelines for the management of severe acute pancreatitis","volume":"14","author":"Lepp\u00e4niemi","year":"2019","journal-title":"World J Emerg Surg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2214\/ajr.166.5.8615248","article-title":"CT evaluation of acute cholecystitis: findings and usefulness in diagnosis","volume":"166","author":"Fidler","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2214\/ajr.181.1.1810115","article-title":"Dynamic CT of acute cholangitis: early inhomogeneous enhancement of the liver","volume":"181","author":"Arai","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/187221311795399255","article-title":"Tyrosine kinase inhibitors, pancreatic hyperenzymemia and acute pancreatitis: a review","volume":"5","author":"Pezzilli","year":"2011","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12328-020-01116-5","article-title":"Lenvatinib-induced acute acalculous cholecystitis in a patient with hepatocellular carcinoma","volume":"13","author":"Ishigaki","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jjco\/hyz009","article-title":"Efficacy and safety of sunitinib in Japanese patients with progressive, advanced\/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study","volume":"49","author":"Ito","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"R19-20250504","first-page":"302","article-title":"Acute acalculous cholecystitis in patients with clear cell renal cell carcinoma treated with sunitinib: report of two cases","volume":"6","author":"Furubayashi","year":"2014","journal-title":"J Clin Med Res"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1592\/phco.27.5.775","article-title":"Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib","volume":"27","author":"de Lima Lopes","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3816\/CGC.2009.n.011","article-title":"Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib","volume":"7","author":"Gomez-Abuin","year":"2009","journal-title":"Clin Genitourin Cancer"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4081\/cp.2014.635","article-title":"Acute acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib","volume":"4","author":"da Fonseca","year":"2014","journal-title":"Clin Pract"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1752-1947-6-69","article-title":"Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report","volume":"6","author":"Nakano","year":"2012","journal-title":"J Med Case Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4251\/wjgo.v4.i5.115","article-title":"A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma","volume":"4","author":"Aihara","year":"2012","journal-title":"World J Gastrointest Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc2152","article-title":"Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition","volume":"7","author":"Verheul","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bmj.39267.452257.AD","article-title":"Gallstones","volume":"335","author":"Sanders","year":"2007","journal-title":"BMJ"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archsurg.135.9.1021","article-title":"The spectrum and cost of complicated gallstone disease in California","volume":"135","author":"Glasgow","year":"2000","journal-title":"Arch Surg"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00330-014-3389-1","article-title":"Incidence of bowel wall oedema on computed tomography exams and association with diarrhoea in renal cell carcinoma patients treated with sunitinib","volume":"25","author":"Cornelissen","year":"2015","journal-title":"Eur Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:26:03Z","timestamp":1746336363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027182"}},"subtitle":["A single-center, retrospective study"],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":26,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027182","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"2021-05-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}